David's Discussions (348)

Discussions Replied To (313) Replies Latest Activity

"Another company willing to run trial on non ambulatory subjects. I hope they have PP…"

David replied Aug 3, 2015 to FibroGen Receives FDA Clearance to Proceed With Clinical Study of FG-3019 in DMD

1 Aug 3, 2015
Reply by David

"However, waiting for market approval is itself a risk. How long? Nobody truly knows."

David replied Jul 13, 2015 to No steroids ... Any other options?

6 Jul 23, 2015
Reply by wainaina muiruri

"Could be wrong, but the steroid condition us added to trial simply to ensure the stu…"

David replied Jul 13, 2015 to No steroids ... Any other options?

6 Jul 23, 2015
Reply by wainaina muiruri

"I asked them some years ago how many other registrants matched my son's exon profile…"

David replied Jul 6, 2015 to similarities in diagnosis

3 Jul 6, 2015
Reply by David

"No growth hormones, no."

David replied Jul 4, 2015 to participating in research trials

13 Jul 9, 2015
Reply by Robin Taylor

"Have you joined Duchenne Connect? This is exactly the info they gather across the co…"

David replied Jul 4, 2015 to similarities in diagnosis

3 Jul 6, 2015
Reply by David

"My son has found the side effects of Deflazacort more manageable than prednisone. He…"

David replied Jun 30, 2015 to participating in research trials

13 Jul 9, 2015
Reply by Robin Taylor

"I work as an internet engineer. I heard of some families getting together and sharin…"

David replied Jun 21, 2015 to Childcare before and afterschool

5 Jun 22, 2015
Reply by Ellen Corbin

"I am thankful to have been working at home since my boy was 7. I don't know how you…"

David replied Jun 20, 2015 to Childcare before and afterschool

5 Jun 22, 2015
Reply by Ellen Corbin

"Yes, the OSU trial involves MRI.The echo results are not from the trial but from reg…"

David replied Jun 11, 2015 to Eplerenone

9 Jun 11, 2015
Reply by David

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2019   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service